Anti-convulsants and anti-depressants.

作者: A. H. Dickenson , J. Ghandehari

DOI: 10.1007/978-3-540-33823-9_6

关键词:

摘要: Damage to a nerve should only lead sensory loss. While this is common, the incidence of spontaneous pain, allodynia and hyperalgesia indicate marked changes in nervous system that are possible compensations for loss normal function arises from Neuropathic pain damaged which then alter spinal cord brain plasticity areas adjacent those directly influenced by neuropathy. The peripheral drive central so mechanisms involved multiple located at number sites. Nerve damage increases excitability both undamaged fibres, neuromas cell bodies dorsal root ganglion. These substrates ongoing efficacy blockers such as carbamazepine, lamotrigine mexiletine, all anti-convulsants. A better understanding ion channels sites injury has shown important roles particular sodium, potassium calcium genesis neuropathic pain. Within cord, activity receptors glutamate, especially N-methyl-D-aspartate (NMDA) receptor, trigger wind-up hyperexcitability. Increases transmitter release, neuronal receptive field size result nerves. Ketamine gabapentin/pregabalin, again with anticonvulsant activity, may interact these mechanisms. acts on whereas gabapentin subunit responsible release transmitters into cord. In addition hyperexcitability, cells participate spinal-supraspinal loop involves parts affective responses but also engages descending excitatory inhibitory systems use monoamines. pathways become more active after site action anti-depressants. This chapter reviews evidence drugs, anti-depressants anticonvulsants, believed be effective control, major emphasis state.

参考文章(135)
Sally L Collins, R.Andrew Moore, Henry J McQuay, Philip Wiffen, Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. Journal of Pain and Symptom Management. ,vol. 20, pp. 449- 458 ,(2000) , 10.1016/S0885-3924(00)00218-9
Christopher D. Saudek, Steven Werns, Marcus M. Reidenberg, Phenytoin in the treatment of diabetic symmetrical polyneuropathy Clinical Pharmacology & Therapeutics. ,vol. 22, pp. 196- 199 ,(1977) , 10.1002/CPT1977222196
F Coluzzi, F Paoletti, C Mattia, A Boanelli, New antidepressants in the treatment of neuropathic pain. A review. Minerva Anestesiologica. ,vol. 68, pp. 105- 114 ,(2002)
J. B. Peiris, G. L. S. Perera, S. V. Devendra, N. D. W. Lionel, Sodium valproate in trigeminal neuralgia. The Medical Journal of Australia. ,vol. 2, pp. 278- 278 ,(1980) , 10.5694/J.1326-5377.1980.TB131854.X
David Clifford, Treatment of pain with antidepressants. American Family Physician. ,vol. 31, pp. 181- 185 ,(1985)
D. J. Maxwell, R. Kerr, S. Rashid, E. Anderson, Characterisation of axon terminals in the rat dorsal horn that are immunoreactive for serotonin 5-HT3A receptor subunits. Experimental Brain Research. ,vol. 149, pp. 114- 124 ,(2003) , 10.1007/S00221-002-1339-7
Ivo W. Tremont-Lukats, Carla Megeff, Misha-Miroslav Backonja, Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs. ,vol. 60, pp. 1029- 1052 ,(2000) , 10.2165/00003495-200060050-00005
S. H. Sindrup, T. S. Jensen, Pharmacologic treatment of pain in polyneuropathy Neurology. ,vol. 55, pp. 915- 920 ,(2000) , 10.1212/WNL.55.7.915
Andrew J. Todd, Zita Puskár, Rosemary C. Spike, Catriona Hughes, Christine Watt, Lisa Forrest, Projection Neurons in Lamina I of Rat Spinal Cord with the Neurokinin 1 Receptor Are Selectively Innervated by Substance P-Containing Afferents and Respond to Noxious Stimulation The Journal of Neuroscience. ,vol. 22, pp. 4103- 4113 ,(2002) , 10.1523/JNEUROSCI.22-10-04103.2002
Z. David Luo, Sandra R. Chaplan, Emiliano S. Higuera, Linda S. Sorkin, Kenneth A. Stauderman, Mark E. Williams, Tony L. Yaksh, Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. The Journal of Neuroscience. ,vol. 21, pp. 1868- 1875 ,(2001) , 10.1523/JNEUROSCI.21-06-01868.2001